|
Audited Financial Results
for the Quarter Ended on June 30,2002 ::
( Rs. in lacs except per share data )
| PARTICULARS |
Three
Months
Ended On |
Accounting
Year Ended On |
| |
30-06-2002 |
30-06-2001 |
31-03-2002
|
| Sales & Income
from Operations |
11566 |
10963 |
44222
|
| Expenditure |
- |
- |
- |
(Increase)/Decrease in Stock in Trade
|
633 |
558 |
666
|
Consumption of Raw/Packing Material
|
3443 |
3540 |
14987 |
Staff Cost
|
916 |
656 |
3019 |
Manufacturing & Other Expenses
|
1234 |
1271 |
4901 |
Selling Expenses
|
866 |
889 |
3813 |
Research & Development Expenses
|
520 |
568 |
2043 |
Excise Duty & Sales Tax
|
1908 |
1600 |
6721 |
| - |
- |
- |
- |
| Total Expenditure |
9520 |
9082 |
36150 |
| - |
- |
- |
- |
| Operating Profit
before Interest, Depreciation & Tax |
2046 |
1881 |
8072 |
| - |
- |
- |
- |
Net Interest Expense (income)
|
(12) |
107 |
463 |
Depreciation
|
382 |
363 |
1423 |
| - |
- |
- |
- |
Operating Profit before Tax
|
1676 |
1411 |
6186 |
Other Income
|
23 |
76 |
354 |
| - |
- |
- |
- |
Profit before Tax and Exceptional
Items
|
1699 |
1487 |
6540 |
Provision for Taxation
[see note]
|
- |
- |
- |
Current Tax
|
451 |
481 |
1996 |
Deferred Tax
|
30 |
(27) |
(602) |
(Excess)/Short Provision of Tax of Earlier
Years
|
0 |
0 |
85 |
| - |
481 |
454 |
1479 |
| - |
- |
- |
- |
| Profit after Tax and before
Exceptional Items |
1218 |
1033 |
5061 |
| Prior
Period Adjustment |
- |
- |
- |
| Exceptional
Items |
- |
- |
(75) |
| - |
- |
- |
- |
| Net Profit/(Loss) for the
Period |
1218 |
1033 |
4986 |
| - |
- |
- |
- |
| Paid-up Equity Share Capital
[Face Value Rs.10] |
2110 |
2108 |
2108 |
| Reserves excluding revaluation
reserves |
- |
- |
20831 |
| Basic & Diluted EPS for
the period |
5.76 |
4.88 |
23.56 |
Basic & Diluted EPS for
the period on Profit after Tax and before
Exceptional Items
|
5.76 |
4.88 |
23.92
|
| - |
- |
- |
- |
Non-Promoter shareholding
|
- |
- |
- |
Number of shares
|
5525066 |
5526473 |
5528897 |
Percentage of shareholding
|
26.11% |
26.12% |
26.13%
|
NOTES:
| (1) |
The above results were reviewed
by the Audit Committee and approved by the
Board of Directors, in their respective
meetings held on 22 July 2002. There is
no qualification in the Auditors report
for the period. |
| (2a) |
This statement of financial results has
been prepared by applying the same accounting
policies as were applied in the most recent
annual financial statements for the year
2001-02. |
| (2b) |
Based on a review of potential future
benefits, the Company wrote off the entire
balance in Deferred Revenue Expenditure
(comprising of Research & Development
Expenses & Market Development Expenditure)
in the annual financial statements for 2001-02.
The expenditure for the first quarter of
the previous year includes Rs.72 lacs on
account of amortisation of such Deferred
Revenue Expenditure. |
| (3) |
The figures for the previous year have
been regrouped to render them comparable
with the figures for the current year. |
| (4) |
The Company operates in a solitary business
segment viz. pharmaceuticals, comprising
mainly manufacture of branded formulations.
A further breakdown of pharmaceutical sales
is given below. |
Rs. Lacs
| Particulars |
Quarter Ended |
Year Ended |
| -
|
30-Jun
2002 |
30-Jun
2001 |
Growth (%) |
31-Mar
2002 |
| Domestic Formulations |
8311 |
7712 |
7.8% |
30224 |
| Exports |
754 |
724 |
4.1% |
3652 |
| Contract Manufacture |
1861 |
1907 |
-2.4% |
7861 |
| Others * |
349 |
383 |
-8.9% |
1457 |
| Total |
11275 |
10726 |
5.1% |
43194 |
* include inter-unit transfer for captive consumption,
current quarter Rs.270 lacs (previous quarter
Rs.229 lacs).
Sales include excise duty and sales tax.
| (5a) |
During the quarter the Company
has repaid Rs.1825 lacs of long term secured
borrowing. |
| (5b) |
The Company made further investments during
the quarter amounting to Rs 249 lacs in
equity shares of Torrent Do Brasil Ltda
, its wholly owned subsidiary at Brazil.
|
| |
For TORRENT PHARMACEUTICALS LIMITED
Sd/- |
Ahmedabad
22 July 2002. |
Samir
Metha
Managing Director |
|
